Next Article in Journal
Interleukin-6 and Its Soluble Receptor Complex in Intensive Care Unit COVID-19 Patients: An Analysis of Second Wave Patients
Previous Article in Journal
Plasmodium Infection–Cure Cycles Increase the Capacity of Phagocytosis in Conventional Dendritic Cells
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Therapeutic Strategies against Leishmania and Trypanosoma

by
André L. S. Santos
1,*,
Igor A. Rodrigues
2,
Claudia M. d’Avila-Levy
3,
Cátia L. Sodré
4,
Koert Ritmeijer
5 and
Marta H. Branquinha
1
1
Laboratório de Estudos Avançados de Microrganismos Emergentes e Resistentes (LEAMER), Departamento de Microbiologia Geral, Instituto de Microbiologia Paulo de Góes (IMPG), Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro 21941-902, RJ, Brazil
2
Departamento de Produtos Naturais e Alimentos, Faculdade de Farmácia, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro 21941-902, RJ, Brazil
3
Laboratório de Estudos Integrados em Protozoologia, Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Coleção de Protozoários da Fiocruz, Rio de Janeiro 21040-900, RJ, Brazil
4
Departamento de Biologia Celular e Molecular (GCM), Instituto de Biologia (IB), Universidade Federal Fluminense (UFF), Niterói 24210-201, RJ, Brazil
5
Public Health Department, Médecins Sans Frontières, 1018 DD Amsterdam, The Netherlands
*
Author to whom correspondence should be addressed.
Pathogens 2023, 12(10), 1263; https://doi.org/10.3390/pathogens12101263
Submission received: 30 September 2023 / Accepted: 19 October 2023 / Published: 19 October 2023

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Human African trypanosomiasis (also known as sleeping sickness, with Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense as etiological agents), American trypanosomiasis (also known as Chagas disease, with Trypanosoma cruzi as the etiological agent), and leishmaniasis (including cutaneous, mucocutaneous, and visceral forms, with multiple species belonging to the Leishmania genus as etiological agents) are recognized as neglected tropical diseases (NTDs) [...]

Share and Cite

MDPI and ACS Style

Santos, A.L.S.; Rodrigues, I.A.; d’Avila-Levy, C.M.; Sodré, C.L.; Ritmeijer, K.; Branquinha, M.H. Therapeutic Strategies against Leishmania and Trypanosoma. Pathogens 2023, 12, 1263. https://doi.org/10.3390/pathogens12101263

AMA Style

Santos ALS, Rodrigues IA, d’Avila-Levy CM, Sodré CL, Ritmeijer K, Branquinha MH. Therapeutic Strategies against Leishmania and Trypanosoma. Pathogens. 2023; 12(10):1263. https://doi.org/10.3390/pathogens12101263

Chicago/Turabian Style

Santos, André L. S., Igor A. Rodrigues, Claudia M. d’Avila-Levy, Cátia L. Sodré, Koert Ritmeijer, and Marta H. Branquinha. 2023. "Therapeutic Strategies against Leishmania and Trypanosoma" Pathogens 12, no. 10: 1263. https://doi.org/10.3390/pathogens12101263

APA Style

Santos, A. L. S., Rodrigues, I. A., d’Avila-Levy, C. M., Sodré, C. L., Ritmeijer, K., & Branquinha, M. H. (2023). Therapeutic Strategies against Leishmania and Trypanosoma. Pathogens, 12(10), 1263. https://doi.org/10.3390/pathogens12101263

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop